학술논문
Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
Document Type
Article
Author
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2023, 14)
Subject
Language
English
ISSN
16643224